APO-GATIFLOXACIN 0.3 %
GATIFLOXACIN (GATIFLOXACIN HEMIHYDRATE) : 0.3 % · DIN 02327260 · APOTEX INC
Health Canada status: MARKETED
What is APO-GATIFLOXACIN?
APO-GATIFLOXACIN 0.3 % contains GATIFLOXACIN (GATIFLOXACIN HEMIHYDRATE) : 0.3 %. It is listed in the Health Canada Drug Product Database under DIN 02327260, held by APOTEX INC, supplied as SOLUTION for OPHTHALMIC administration. Health Canada currently lists it as marketed, status dated 15-Nov-2019. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is APO-GATIFLOXACIN used for?
APO-GATIFLOXACIN (gatifloxacin ophthalmic solution) is indicated for the treatment of patients 1 year of age and older with bacterial conjunctivitis caused by susceptible strains of various aerobic Gram-positive and Gram-negative bacteria. It should be used only to treat infections proven or strongly suspected to be caused by susceptible bacteria to reduce drug-resistant bacteria.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02327260 |
|---|---|
| Brand name | APO-GATIFLOXACIN |
| Generic / active ingredient | GATIFLOXACIN (GATIFLOXACIN HEMIHYDRATE) : 0.3 % |
| Manufacturer | APOTEX INC |
| Strength | 0.3 % |
| Dosage form | SOLUTION |
| Route of administration | OPHTHALMIC |
| Schedule | Prescription |
| ATC code | S01AE06 GATIFLOXACIN |
| AHFS class | 52:04.04 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 15-Nov-2019 |
| Original market date | 2019-11-15 00:00:00 |
How is it stored and handled?
null
How is it supplied?
5 mL size
What can be used instead?
Other Canadian products sharing ATC code S01AE06 GATIFLOXACIN. 3 of 4 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| JAMP GATIFLOXACIN | 0.3 % | SOLUTION | JAMP PHARMA CORPORATION | MARKETED | DIN 02533235 |
| ZYMAR | 0.3 % | SOLUTION | ABBVIE CORPORATION | MARKETED | DIN 02257270 |
| SANDOZ GATIFLOXACIN | 3 MG | SOLUTION | SANDOZ CANADA INCORPORATED | CANCELLED PRE MARKET | DIN 02408481 |
Who else supplies GATIFLOXACIN worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. GATIFLOXACIN appears in 665 registered pack listings across 3 markets, published on 2 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.